Optimizing hepatitis B virus screening in the United States using a simple demographics-based model
- PMID: 34496066
- DOI: 10.1002/hep.32142
Optimizing hepatitis B virus screening in the United States using a simple demographics-based model
Abstract
Background and aims: Chronic hepatitis B (CHB) affects >290 million persons globally, and only 10% have been diagnosed, presenting a severe gap that must be addressed. We developed logistic regression (LR) and machine learning (ML; random forest) models to accurately identify patients with HBV, using only easily obtained demographic data from a population-based data set.
Approach and results: We identified participants with data on HBsAg, birth year, sex, race/ethnicity, and birthplace from 10 cycles of the National Health and Nutrition Examination Survey (1999-2018) and divided them into two cohorts: training (cycles 2, 3, 5, 6, 8, and 10; n = 39,119) and validation (cycles 1, 4, 7, and 9; n = 21,569). We then developed and tested our two models. The overall cohort was 49.2% male, 39.7% White, 23.2% Black, 29.6% Hispanic, and 7.5% Asian/other, with a median birth year of 1973. In multivariable logistic regression, the following factors were associated with HBV infection: birth year 1991 or after (adjusted OR [aOR], 0.28; p < 0.001); male sex (aOR, 1.49; p = 0.0080); Black and Asian/other versus White (aOR, 5.23 and 9.13; p < 0.001 for both); and being USA-born (vs. foreign-born; aOR, 0.14; p < 0.001). We found that the ML model consistently outperformed the LR model, with higher area under the receiver operating characteristic values (0.83 vs. 0.75 in validation cohort; p < 0.001) and better differentiation of high- and low-risk persons.
Conclusions: Our ML model provides a simple, targeted approach to HBV screening, using only easily obtained demographic data.
© 2021 American Association for the Study of Liver Diseases.
Comment in
-
Reply.Hepatology. 2022 Apr;75(4):1063-1064. doi: 10.1002/hep.32303. Epub 2022 Jan 11. Hepatology. 2022. PMID: 34951716 No abstract available.
-
Letter to the editor: Importance of universal screening for chronic hepatitis B infection in adults in the United States.Hepatology. 2022 Apr;75(4):1062-1063. doi: 10.1002/hep.32304. Epub 2022 Jan 8. Hepatology. 2022. PMID: 34951931 No abstract available.
References
-
- Polaris Observatory Collaborators . Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3:383–403.
-
- Wong RJ, Brosgart CL, Welch S, Block T, Chen M, Cohen C, et al. An updated assessment of chronic hepatitis B prevalence among foreign‐born persons living in the United States. Hepatology. 2021;74:607–26.
-
- Le MH, Yeo YH, Cheung R, Henry L, Lok AS, Nguyen MH. Chronic hepatitis B prevalence among foreign‐born and U.S.‐born adults in the United States, 1999–2016. Hepatology. 2020;71:431–43.
-
- Lim JK, Nguyen MH, Kim WR, Gish R, Perumalswami P, Jacobson IM. Prevalence of chronic hepatitis B virus infection in the United States. Am J Gastroenterol. 2020;115:1429–38.
-
- Ogawa E, Yeo YH, Dang N, Le MH, Jeong D, Tran S, et al. Diagnosis rates of chronic hepatitis B in privately insured patients in the United States. JAMA Netw Open. 2020;3:e201844.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous